Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-05 12:52 pm Purchase |
2025-04-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
First Eagle Investment Management LLC | 2,294,261 10.000% |
724,479 (+46.15%) |
Filing History |
| 2025-05-05 12:16 pm Purchase |
2025-03-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
First Eagle Investment Management LLC | 1,569,782 6.800% |
1,569,782 (New Position) |
Filing History |
| 2025-03-04 7:06 pm Purchase |
2025-02-10 | 13G | OncoCyte Corporation OCX |
BIO-RAD LABORATORIES INC. BIO |
2,764,078 9.700% |
2,764,078 (New Position) |
Filing History |
| 2024-12-20 4:50 pm Purchase |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 1,907,640 8.370% |
1,716,876 (+900.00%) |
Filing History |
| 2024-11-14 5:25 pm Purchase |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
VAN ECK ASSOCIATES CORP | 1,306,473 5.730% |
1,306,473 (New Position) |
Filing History |
| 2024-11-12 1:27 pm Unchanged |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 190,764 8.360% |
0 (Unchanged) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
BlackRock Inc. BLK |
1,929,864 8.500% |
0 (Unchanged) |
Filing History |
| 2024-11-04 11:22 am Sale |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 190,764 8.360% |
-2,236,373 (-92.14%) |
Filing History |
| 2024-10-24 12:13 pm Purchase |
2024-10-04 | 13G | MEDICENNA THERAPEUTICS CORP MDNAF |
BIO-RAD LABORATORIES INC. BIO |
1,510,944 8.970% |
1,510,944 (New Position) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
BlackRock Inc. BLK |
1,929,864 8.500% |
463,638 (+31.62%) |
Filing History |
| 2024-10-10 11:38 am Sale |
2023-12-29 | 13G | Bio-Rad Laboratories, Inc. BIO |
BANK OF NOVA SCOTIA | 22,572 0.090% |
-1,581,474 (-98.59%) |
Filing |
| 2024-10-10 11:36 am Purchase |
2022-12-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
BANK OF NOVA SCOTIA | 1,604,046 6.500% |
1,604,046 (New Position) |
Filing |
| 2024-04-22 1:30 pm Purchase |
2024-04-15 | 13G | Bio-Rad Laboratories, Inc. BIO |
BIO-RAD LABORATORIES INC. BIO |
1,200,109 8.990% |
1,200,109 (New Position) |
Filing History |
| 2024-03-11 09:59 am Purchase |
2024-02-29 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 2,427,137 10.360% |
37,248 (+1.56%) |
Filing History |
| 2024-02-13 5:00 pm Sale |
2023-12-29 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 2,389,889 9.930% |
-1,547 (-0.06%) |
Filing History |
| 2024-01-29 5:25 pm Sale |
2023-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
BlackRock Inc. BLK |
1,466,226 6.100% |
-116,087 (-7.34%) |
Filing History |
| 2023-02-09 11:12 am Purchase |
2022-12-30 | 13G | Bio-Rad Laboratories, Inc. BIO |
The Vanguard Group | 2,391,436 9.660% |
103,971 (+4.55%) |
Filing History |
| 2023-02-09 08:23 am Sale |
2023-02-09 | 13G | Bio-Rad Laboratories, Inc. BIO |
FMR LLC | 235,684 0.952% |
-1,692,639 (-87.78%) |
Filing History |
| 2023-01-31 5:52 pm Sale |
2022-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO |
BlackRock Inc. BLK |
1,582,313 6.400% |
-185,768 (-10.51%) |
Filing History |
| 2022-04-11 4:46 pm Sale |
2021-11-09 | 13D | BIO RAD LABORATORIES BIOB |
SCHWARTZ ALICE N | 4,555,452 89.700% |
-522 (-0.01%) |
Filing History |